| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |